396 participants
Evaluation of Recombinant Humanized Anti-CD25 Monoclonal Antibody for Preventing Graft-versus-host Disease After Haploidentical/matched Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients with Transfusion-dependent Thalassemia
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-10-28
- Start Date:
- 2024-10-01
- Completion:
- 2027-09-30
Conditions
- Transfusion Dependent Thalassemia
Interventions
- DRUG
No Results Yet